Over the last decades, transcriptome profiling emerged as one of the most powerful
approaches in oncology, providing prognostic and predictive utility for cancer management …

Growing bodies of evidence have demonstrated that the identification of prostate cancer
(PCa) biomarkers in the patients' blood and urine may remarkably improve PCa diagnosis …

Exosomes have shown great potential in disease diagnostics and therapeutics. However,
current isolation approaches are burdensome and suffer from low speed, yield and purity …

High-precision isolation of small extracellular vesicles (sEVs) from biofluids is essential
toward developing next-generation liquid biopsies and regenerative therapies. However …

Prostate cancer (PCa) is the second most common cause of cancer-related mortality among
men in the developed world. Conventional anti-PCa therapies are not effective for patients …

Prostate cancer is a leading cause of death worldwide and new estimates revealed prostate
cancer as the leading cause of death in men in 2021. Therefore, new strategies are pertinent …

Simple Summary Patients with lung cancer have high rates of brain metastasis (BM).
Despite available therapies, patient prognosis is poor. Studies have shown genetic …

Context Genomic testing is becoming increasingly important in patients with advanced
prostate cancer (PC) and is being incorporated in clinical practice to guide treatment …

Simple Summary Early diagnosis of colorectal cancer (CRC) is crucial to improve patient
outcomes. The tumour microenvironment immediately adapts to malignant transformations …

Cancer represents one of the conditions with the most causes of death worldwide. Common
methods for its diagnosis are based on tissue biopsies—the extraction of tissue from the …